Male Breast Cancer

  • Tracey Irvine
  • Ian S. Fentiman


Male breast cancer (MBC) is a relatively rare disease, accounting for <1% of all breast cancers in the western world and 0.1% of cancer deaths in men . The causes are still poorly understood and the low incidence of MBC means that studies are small and underpowered. The treatment of MBC is based on large trials in postmenopausal women. The outlook for men is the same as women stage for stage, but overall the prognosis tends to be poorer. This is usually due to a delay in presentation – despite increasing awareness of MBC, there remains an average delay from the onset of symptoms to diagnosis of 6–10 months, with little improvement in survival over the last 25 years.


Breast Cancer Human Epidermal Growth Factor Receptor Aromatase Inhibitor Inflammatory Breast Cancer Invasive Lobular Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Nat Cancer Inst. 2003;95:1276–99.PubMedCrossRefGoogle Scholar
  2. 2.
    Joshi MG, Lee AK, Loda M, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer. 1996;77:490–8.PubMedCrossRefGoogle Scholar
  3. 3.
    O’Malley CD, Prehn AW, Shema SJ, et al. Racial/ethnic differences in survival rates in a population based series of men with breast cancer. Cancer. 2002;94:2836–42.PubMedCrossRefGoogle Scholar
  4. 4.
    Sheik O. Male breast cancer: factors influencing prognosis. Br J Cancer. 1975;30:13–35.Google Scholar
  5. 5.
    Hodgson NC, Button JH, Franceschi D, et al. Male breast cancer: is the incidence increasing? Ann Surg Oncol. 2004;2010(8):751–5.CrossRefGoogle Scholar
  6. 6.
    Mabuchi K, Bross DS, Kessler II. Risk factors for male breast cancer. J Natl Cancer Inst. 1985;74:371–5.PubMedGoogle Scholar
  7. 7.
    Ojara EA. Carcinoma of the male breast in Mulago Hospital, Kampala. East Afr Med J. 1978;55:489–91.PubMedGoogle Scholar
  8. 8.
    Bhagwandin S. Carcinoma of the male breast in Zambia. East Afr Med J. 1972;49:176–9.Google Scholar
  9. 9.
    Waterhouse J, Muir C, Correa P, et al. Cancer incidence in five continents, vol 3. IARC Sci Publ 1976;(15):1–583.Google Scholar
  10. 10.
    Anderson WF, Althius MD, Brinton LA, et al. Is male breast cancer similar or different from female breast cancer? Br Cancer Res Treat. 2004;83:77–86.CrossRefGoogle Scholar
  11. 2010.
    Basham VM, Lipscombe JM, Ward JM, et al. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res. 2002;4(1):R2.PubMedCrossRefGoogle Scholar
  12. 12.
    Friedman LS, Gayther SA, Kurosaki T, et al. Mutation analysis of BRCA1 and BRCA2 ­mutations in a male breast cancer population. Am J Hum Genet. 1997;60:313–9.PubMedGoogle Scholar
  13. 13.
    Fackenthal JD, Marsh DJ, Richardson AL, et al. Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet. 2001;38:159–64.PubMedCrossRefGoogle Scholar
  14. 14.
    Harnden DG, Maclean N, Langlands AO. Carcinoma of the breast and Klinefelter’s syndrome. J Med Genet. 1971;8:460–1.PubMedCrossRefGoogle Scholar
  15. 15.
    Price WH, Clayton JF, Wilson J, Collyer S, De Mey R. Causes of death in X chromatin positive males (Klinefelter’s syndrome). J Epidemiol Community Health. 1985;39:330–6.PubMedCrossRefGoogle Scholar
  16. 16.
    McLaughlin JK, Malker BR, Blot WJ, et al. Occupational risks for male breast cancer in Sweden. Br J Indust Med. 1988;4:275–6.Google Scholar
  17. 17.
    Hansen J. Elevated risk for male breast cancer after exposure to gasoline and vehicular combustion products. Am J Ind Med. 2000;37:349–52.PubMedCrossRefGoogle Scholar
  18. 18.
    Loomis DP. Cancer of breast among men in electrical occupations. Lancet. 1992;339:1482–3.PubMedCrossRefGoogle Scholar
  19. 19.
    Lenfant-Pejovic M-H, Mlika-Cabanne N, Bouchardy C, et al. Risk factors for male breast cancer: a Franco-Swiss case-control study. Int J Cancer. 1990;45:661–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Olsson H, Ranstam J. Head trauma and exposure to Prolactin-elevating drugs as risk factors for male breast cancer. J Natl Cancer Inst. 1988;80:679–83.PubMedCrossRefGoogle Scholar
  21. 21.
    Sasco AJ, Lowenfels AB, Pasker de Jong P. Epidemiology of male breast cancer: a meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer. 1993;53:539–49.CrossRefGoogle Scholar
  22. 22.
    Ron E, Ikeda T, Preston DL, et al. Male breast cancer incidence among atomic bomb survivors. J Natl Cancer Inst. 2005;97:603–5.PubMedCrossRefGoogle Scholar
  23. 23.
    McClure JA, Higgins CC. Bilateral carcinoma of male breast after estrogen therapy. JAMA. 1951;146:7–9.CrossRefGoogle Scholar
  24. 24.
    Symmers WSC. Carcinoma of the breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sexual characteristics. Br Med J. 1968;2:83–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Thomas DB, Jimenez LM, McTiernan A, et al. Breast cancer in men: risk factors with ­hormonal implications. Am J Epidemiol. 1992;135:734–48.PubMedGoogle Scholar
  26. 26.
    Johnson KC, Pan S, Mao Y. Risk factors for male breast cancer in Canada, 1994-1998. Eur J Cancer Prev. 2002;2010:253–63.CrossRefGoogle Scholar
  27. 27.
    Hsing AW, McLaughlin JK, Cocco P, et al. Risk factors for male breast cancer (United States). Cancer Causes Control. 1998;9:269–76.PubMedCrossRefGoogle Scholar
  28. 28.
    Guenel P, Cyr D, Sabroe S, et al. Alcohol drinking may increase the risk of breast cancer in men: a European population-based case-control study. Cancer Causes Control. 2004;15:571–80.PubMedCrossRefGoogle Scholar
  29. 29.
    Volm MD, Talamonti MS, Thangavelu M, et al. Pituitary adenoma and bilateral male breast cancer: an unusual association. J Surg Oncol. 1997;64:74–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Ribeiro GG, Swindell R, Harris M, et al. A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. Breast. 1996;5:141–6.CrossRefGoogle Scholar
  31. 31.
    van Geel AN, van Slooten EA, Mavrunac M, et al. A retrospective study of male breast cancer in Holland. Br J Surg. 1985;72:724–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Goss PE, Reid C, Pintilie M, et al. Male breast carcinoma: a review of 229 cases who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer. 1999;85:629–39.PubMedCrossRefGoogle Scholar
  33. 33.
    Scheike O. Male breast cancer. Acta Pathol Microbiol Scand. 1975;S251:3–35.Google Scholar
  34. 34.
    Ramantanis G, Besbeas S, Garas JG, et al. Breast cancer in the male: a report of 138 cases. World J Surg. 1980;4:621–4.PubMedCrossRefGoogle Scholar
  35. 35.
    Stewart RAL, Howlett DC, Hearn FJ. Pictorial review: the imaging features of male breast disease. Clin Radiol. 1997;52:739–44.PubMedCrossRefGoogle Scholar
  36. 36.
    Donegan WL, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast in males. Cancer. 1998;83:498–509.PubMedCrossRefGoogle Scholar
  37. 37.
    Stalsberg H, Thomas DB, Rosenblatt KA, et al. Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men. Cancer Causes Control. 1993;4:143–51.PubMedCrossRefGoogle Scholar
  38. 38.
    Giordano SH, Cohen DS, Buzdar AU, et al. Breast carcinoma in men: a population based study. Cancer. 2004;101:51–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Michaels BM, Nunn CR, Roses DF. Lobular carcinoma of the male breast. Surgery. 1994;20105:402–5.Google Scholar
  40. 40.
    Rayson D, Erlichman C, Suman VJ, et al. Molecular markers in male breast carcinoma. Cancer. 1998;83:2139–49.CrossRefGoogle Scholar
  41. 41.
    Meijer-van Gelder ME, Look MP, Bolt-de Vries J, et al. Clinical relevance of biologic factors in male breast cancer. Breast Cancer Res Treat. 2001;68:249–60.PubMedCrossRefGoogle Scholar
  42. 42.
    Bloom KJ, Govil H, Gattuso P, et al. Status of HER-2 in male and female breast carcinomas. Am J Surg. 2001;82:389–92.CrossRefGoogle Scholar
  43. 43.
    Scott-Connor CE, Jochimsen PR, Menck HR, et al. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery. 1999;126:775–80.CrossRefGoogle Scholar
  44. 44.
    France L, Michie S, Barrett-Lee P, et al. Male breast cancer: a qualitative study of male breast cancer. Breast. 2000;9:342–8.CrossRefGoogle Scholar
  45. 45.
    Spear SL, Bowen DG. Breast reconstruction in a male with a transverse rectus abdominis flap. Plast Reconstr Surg. 1998;102:1615–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Albo D, Ames FC, Hunt KK, et al. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat. 2003;77:9–14.PubMedCrossRefGoogle Scholar
  47. 47.
    Ribeiro G, Swindell R. Adjuvant tamoxifen for male breast cancer. Br J Cancer. 1992;65:252–4.PubMedCrossRefGoogle Scholar
  48. 48.
    Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 2006;367:595–604.PubMedCrossRefGoogle Scholar
  49. 49.
    Cutuli B, Lacroze M, Dilhuydy JM, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer. 1995;31A:1960–4.PubMedCrossRefGoogle Scholar
  50. 50.
    Erlichman C, Murphy KC, Elhakim T. Male breast cancer: a 13 year review of 89 patients. J Clin Oncol. 1984;2:903–9.PubMedGoogle Scholar
  51. 51.
    Giordano SH, Perkins GH, Broglio K, et al. Adjuvant systemic therapy for male breast cancer. Cancer. 2005;104:235–64.CrossRefGoogle Scholar
  52. 52.
    Yildirim E, Berberoglu U. Male breast cancer: a 22 year experience. Eur J Surg Oncol. 1998;24:548–52.PubMedCrossRefGoogle Scholar
  53. 53.
    Jaiyesimi IA, Buzdar AU, Sahin AA, et al. Carcinoma of the male breast. Ann Internal Med. 1992;20107:771–7.Google Scholar
  54. 54.
    Irvine T, Fentiman S. Male breast cancer. CML Breast Cancer. 2007;19(1):1–6.Google Scholar
  55. 55.
    Guinee VF, Olsson H, Moller T, Shallenberger RC, van den Blink JW, et al. The prognosis of breast cancer in males. A report of 335 cases. Cancer. 1993;71(1):154–61.PubMedCrossRefGoogle Scholar
  56. 56.
    NCCN clinical practice guidelins in Oncology ™ genetic/familial high-risk assessment: breast and ovarian. V.I. 2008. (­genetics_screening.pdf).

Copyright information

© Springer New York 2010

Authors and Affiliations

  1. 1.Department of Academic OncologyGuys Hospital, University of LondonLondonUK

Personalised recommendations